参考文献/References:
[1]Hojjat-Farsangi M,Jeddi-Tehrani M,Razavi SM,et al.Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia[J].Cancer Sci,2009,100(12):2346-2353.
[2]D'Arena G,Simeon V,Auria F,et al.Regulatory T-cells in chronic lymphocytic leukemia:actor or innocent bystander[J].Am J Blood Res,2013,3(1):52-57.
[3]中华医学会血液学分会.中国慢性淋巴细胞白血病的诊断与治疗指南(2011年版)[J].中华血液学杂志,2011,32(7):498-501.
[4]Kiaii S,Kokhaei P,Mozaffari F,et al.T cells from indolent CLL patients apoptosis of leukemic B cells in vitro and have altered gene expression profile[J].Cancer Immunol Immunother,2013,62(1):51-63.
[5]姜焕好,曾东良,吴春凤,等.急性白血病患者治疗前后血清 INF-γ、VEGF、IL-10及IL-12水平的变化及意义[J].医学综述,2012,1(2):299-300.
[6]宋建新,张芹,梅芬,等.慢性粒细胞白血病患者骨髓部分细胞因子的表达及意义[J].国际检验医学杂志,2016,12(23):3255-3257.
[7]宋建新,欧阳红梅,闻艳,等.慢性粒细胞白血病骨髓巨噬细胞表达与细胞因子的相关性[J].广东医学,2017,3(5):1-5.
[8]Mainou-Fowler T,Miller S,Proctor SJ,et al.The levels of TNF alpha,IL-4 andIL-10 production by T-cells in B-cell chronic lymphocytic leukaemia(B-CLL)[J].Leuk Res,2001,25(2):157-163.
[9]Mantovani A,Garlanda C,Allavena P.Molecular path-ways and targets in cancer-related inflammation[J].Ann Med,2010,42(3):161-170.
相似文献/References:
[1]石 沁,欧阳红梅,宋建新.血液病患者骨髓微环境和外周血部分细胞因子水平的对比[J].医学信息,2019,32(13):81.[doi:10.3969/j.issn.1006-1959.2019.13.022]
SHI Qin,OUYANG Hong-mei,SONG Jian-xin.Comparison of Bone Marrow Microenvironment and Peripheral Blood Cytokine Levels in
Patients with Hematological Diseases[J].Journal of Medical Information,2019,32(17):81.[doi:10.3969/j.issn.1006-1959.2019.13.022]
[2]刘鹏江,邓 琦.伊布替尼治慢性淋巴细胞白血病的研究[J].医学信息,2020,33(22):48.[doi:10.3969/j.issn.1006-1959.2020.22.015]
LIU Peng-jiang,DENG Qi.Research of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia[J].Journal of Medical Information,2020,33(17):48.[doi:10.3969/j.issn.1006-1959.2020.22.015]